FUB-PB-22

FUB-PB-22

Systematic (IUPAC) name
quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate
Clinical data
Legal status	CA: Schedule II DE: Anlage II (Prohibited)
Identifiers
CAS Number	1800098-36-5
Chemical data
Formula	C25H17FN2O2
Molar mass	396.41 g/mol
SMILES Fc1ccc(cc1)Cn1cc(c2c1cccc2)C(=O)Oc1cccc2c1nccc2
InChI InChI=1S/C25H17FN2O2/c26-19-12-10-17(11-13-19)15-28-16-21(20-7-1-2-8-22(20)28)25(29)30-23-9-3-5-18-6-4-14-27-24(18)23/h1-14,16H,15H2 Key:ROHVURVXAOMRJY-UHFFFAOYSA-N

FUB-PB-22 is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB₁ receptor and has been sold online as a designer drug.^[1][2]

Legal status

FUB-PB-22 is a Anlage II controlled substance in Germany. It was scheduled in Japan in July 2014.

As of October 2015 FUB-PB-22 is a controlled substance in China.^[3]

It is also banned in Sweden.^[4]

See also

• 5F-PB-22
• AM-2201
• BB-22
• FUB-JWH-018
• AB-FUBINACA
• ADB-FUBINACA
• AMB-FUBINACA
• FDU-PB-22
• FUB-144
• FUB-APINACA
• FUB-NNE1
• MDMB-FUBICA
• MDMB-FUBINACA
• PB-22

References

1. "FUB-PB-22". Southern Association of Forensic Scientists. Retrieved 23 July 2015.
2. Nahoko Uchiyama, Yoshihiko Shimokawa, Ruri Kikura-Hanajiri, Yosuke Demizu, Yukihiro Goda, Takashi Hakamatsuka (February 2015). "A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products". Forensic Toxicology. doi:10.1007/s11419-015-0268-7.
3. "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
4. "Cannabinoider föreslås bli klassificerade som hälsofarlig vara". Folkhälsomyndigheten. 28 May 2014. Retrieved 23 July 2015.